The study, published in BMC Complementary Medicine and Therapies, was conducted by a team led by Sultan Çeçen of Hitit University together with colleagues from Hitit University Erol Olçok Training and Research Hospital and Erciyes University. The trial enrolled 75 patients diagnosed with knee osteoarthritis and randomly assigned them to three groups. One group received Nigella sativa oil, a second received a combination of naproxen and lidocaine gel, a topical formulation pairing a nonsteroidal anti-inflammatory drug with a local anesthetic, and a third received plain vaseline as a control. Each participant applied one milliliter of their assigned preparation to both knees with a two-minute massage, three times daily, for 21 days.

The design of the trial reflects a growing effort to test traditional remedies with the same rigor expected of pharmaceutical agents. Randomization was computer-generated, and the sample size was calculated in advance using the statistical power program G*Power, ensuring the study had a defined chance of detecting a real effect if one existed. The researchers measured outcomes with two well-established clinical tools: the Western Ontario and McMaster Universities Osteoarthritis Index, universally known as WOMAC, which quantifies pain, stiffness, and physical function through validated questionnaires, and direct measurement of knee joint range of motion, abbreviated KJROM, using goniometry. Results were reported as mean differences with 95 percent confidence intervals, the standard language of modern clinical evidence.

The findings were striking. Compared with patients who rubbed vaseline on their knees, those using black cumin oil experienced substantially greater reductions in WOMAC pain scores by day 21, with a between-group mean difference of minus 4.56 points and a confidence interval running from minus 7.99 to minus 1.13, a difference that was statistically significant at p equals 0.010. Stiffness improved as well, with a mean difference of minus 2.12 points and a confidence interval of minus 3.58 to minus 0.66, yielding p equals 0.005. Perhaps most importantly for daily living, physical function scores, the domain that captures how well patients can walk, climb stairs, and manage everyday tasks, dropped by a mean difference of minus 17.32 points, with a confidence interval from minus 28.61 to minus 6.03 and p equals 0.003.

The benefits extended beyond symptoms to joint mechanics. After the researchers adjusted for baseline measurements, the final knee joint range of motion values were significantly better in the black cumin oil group than in the vaseline group. The right knee showed an adjusted mean difference of 4.10 degrees, with a confidence interval of 1.83 to 6.36, and the left knee showed a difference of 5.84 degrees, with a confidence interval of 3.73 to 7.94, both highly significant at p less than 0.001. For patients whose stiffening joints gradually steal the ability to squat, kneel, or walk comfortably, a gain of several degrees of flexion is not a trivial statistic; it can translate into real functional differences in ordinary life.

Equally notable is the safety record. No adverse events were reported in any group during the three-week intervention, a clean profile that stands in contrast to the gastrointestinal, cardiovascular, and renal risks associated with long-term oral nonsteroidal anti-inflammatory drugs, the mainstay of pharmacological osteoarthritis treatment. The trial was approved by the Clinical Research Ethics Committee of the Kayseri City Hospital Traditional and Complementary Medicine Practices Center under the Turkish Ministry of Health, and all participants provided written and verbal informed consent. The study was registered in the Clinical Trials protocol registration system as NCT05541185, although the registration was retrospective, dated August 28, 2022, a methodological caveat that careful readers will notice.

Why might an oil pressed from the seeds of Nigella sativa, a flowering plant cultivated for millennia across the Middle East, South Asia, and North Africa, produce these effects? The seed and its oil contain thymoquinone, the compound most often credited with the plant’s pharmacological activity, along with thymohydroquinone, thymol, and a rich mixture of unsaturated fatty acids including linoleic and oleic acid. Laboratory and animal studies have repeatedly described anti-inflammatory and analgesic properties for these constituents, including modulation of inflammatory mediators and oxidative stress pathways that are also implicated in the cartilage degradation and synovial inflammation of osteoarthritis. The mechanical element of the intervention, a two-minute massage with each application, adds a second layer of plausibility, since massage itself is known to influence local circulation, muscle tension, and pain perception, though the vaseline control group received the identical massage, which helps isolate the specific contribution of the oil.

The trial’s comparative design adds an intriguing dimension. The naproxen and lidocaine gel arm was intended as an active comparator, representing a conventional topical pharmaceutical approach, yet the headline results reported in the paper compare the black cumin oil group against the vaseline placebo group. The authors frame Nigella sativa oil as an adjunct to standard medical treatment rather than a replacement for it, a positioning that matters clinically: patients in the study continued their usual care, and the oil was layered on top as a complementary therapy. This framing aligns with a broader shift in rheumatology and rehabilitation medicine toward multimodal management of osteoarthritis, where topical agents, exercise, weight management, and patient education are combined to delay or avoid more invasive interventions.

Caution, however, remains essential. The authors themselves emphasize that the sample size of 75 patients is relatively small and that the study carries methodological limitations, and they explicitly call for larger, adequately powered, multicenter randomized controlled trials to confirm the results. A three-week intervention cannot speak to long-term safety or to whether the benefits persist, accumulate, or fade after treatment stops. The retrospective trial registration, the absence of reported funding, and the open questions about blinding and adherence all warrant attention as the evidence base matures. Osteoarthritis research has a long history of promising early results from supplements and topical remedies that failed to hold up under larger, more rigorous scrutiny, so single trials, however encouraging, should be read as hypothesis-generating rather than practice-changing.

Still, the study is a welcome contribution to a field where patients desperately need more options. Knee osteoarthritis affects hundreds of millions of people worldwide, its prevalence rising with aging populations and obesity, and the gap between conservative care and joint replacement leaves many patients managing chronic pain for decades. If future trials confirm that a simple, inexpensive, topically applied seed oil can meaningfully reduce pain and improve joint mobility with no reported adverse effects, it could become a genuinely useful addition to the conservative management toolkit, particularly in settings where access to pharmacological treatment is limited or where patients prefer natural products. For now, the message from the Çorum researchers is measured but hopeful: black cumin oil, an ancient remedy subjected to a modern randomized trial, may be a promising complementary approach for knee osteoarthritis symptoms, and the scientific community now has a clear mandate to test that promise at scale.

Subject of Research: Topical Nigella sativa oil treatment for pain and physical function in knee osteoarthritis

Article Title: Effects of Nigella sativa oil on pain intensity and physical functions in patients with knee osteoarthritis: a comparative randomized controlled trial

Article References: Çeçen, S., Doğan, A. G., Taşcı, S., Şahin, S., & Doğan, M. (2026). Effects of Nigella sativa oil on pain intensity and physical functions in patients with knee osteoarthritis: a comparative randomized controlled trial. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-026-05567-0

Image Credits: AI Generated

DOI: 10.1186/s12906-026-05567-0

Keywords: knee osteoarthritis, Nigella sativa, black cumin oil, randomized controlled trial, WOMAC, pain management, complementary medicine, joint range of motion, thymoquinone, topical therapy, anti-inflammatory, physical function

The findings are striking in places. Patients who received Nigella sativa were dramatically less likely to develop severe infection symptoms, with a pooled odds ratio of 0.08, meaning the odds of severe disease were reduced by more than ninety percent compared with controls. Mortality told a similar story: death rates were significantly lower in the treatment group, with an odds ratio of 0.216, a reduction the authors calculate at more than 78 percent. Levels of C-reactive protein, a laboratory marker of systemic inflammation that often tracks with COVID-19 severity, fell by an average of 3.29 units in treated patients, a highly statistically significant difference. Headache, one of the most frequently reported symptoms of the disease, was also less common among those taking the supplement.

Yet the analysis is equally notable for what it did not find. Fever, cough, fatigue, runny nose, and shortness of breath, the everyday symptoms that define most COVID-19 cases, showed no statistically significant improvement with black seed. Ferritin, another inflammatory marker, was likewise unchanged. This split pattern, in which mortality and severity improve while routine symptoms do not, suggests that the compound may act on the deeper inflammatory and immunological machinery of the disease rather than on the surface manifestations of infection, a hypothesis consistent with its known pharmacology.

That pharmacology centers on thymoquinone, the principal bioactive constituent of Nigella sativa seeds, along with an array of flavonoids and phenolic compounds. Laboratory and computational studies have shown that these molecules can interact with the complex formed between the SARS-CoV-2 spike protein and the human ACE-2 receptor, the molecular doorway the virus uses to enter cells. Thymoquinone has also been reported to bind the receptor site of transmembrane serine protease 2, the enzyme that primes the spike protein for cell entry, and to reduce oxidative stress while modulating key immune signaling molecules. Together, these actions are thought to lower the likelihood of a cytokine storm, the runaway inflammatory response that drives much of the damage in severe COVID-19.

The seeds also appear to influence the immune system more broadly. Earlier research found that Nigella sativa enhanced natural killer cell activity and improved T-cell immunity, and studies in animal models showed increased interferon-gamma levels and function during viral infection. Clinical experience with other viruses provides supporting context: a formulation of the seed called Alpha-zam selectively inhibited hepatitis C virus replication in cell studies, and a trial in Egypt found that 450 milligrams of black seed oil taken three times daily for three months reduced hepatitis C viral levels by more than half. In laboratory experiments with a coronavirus, seed extract reduced viral load to undetectable levels within six hours of infection, while control samples saw only a ten percent reduction after eight hours.

The new meta-analysis was conducted according to PRISMA guidelines and prospectively registered with PROSPERO. The researchers searched PubMed, Scopus, Web of Science, and Embase for randomized controlled trials published through May 2024, later updating the search to October 2025 without finding additional eligible studies. From an initial harvest of 521 articles, only 24 survived title and abstract screening, and six trials ultimately met the strict inclusion criteria: randomized designs, confirmed COVID-19 patients, Nigella sativa as the intervention, placebo as the comparator, and mortality or clinical symptoms as outcomes. The trials came from Saudi Arabia, Egypt, Iraq, Pakistan, and Iran, and the team assessed each with the Cochrane Revised Risk of Bias tool, finding all six at low overall risk of bias, though most carried some concerns about detection bias.

Statistical synthesis was performed in RevMan version 5.4, with heterogeneity evaluated using Cochran’s Q test. For the headline outcomes, the results were remarkably consistent: severity, CRP, and mortality all showed essentially no heterogeneity across studies, meaning the trials agreed with one another to an unusual degree. Fever and fatigue, by contrast, displayed very high heterogeneity, with I-squared values above ninety percent, indicating that the individual trials disagreed substantially about whether those symptoms improved. The authors note that publication bias could not be assessed and meta-regression could not be performed because too few studies were available, an important caveat when interpreting pooled estimates built on just six trials.

Combination therapy emerged as a particularly intriguing thread in the underlying trials. When Nigella sativa was given together with honey in a multicenter Pakistani placebo-controlled trial, symptom duration fell by half, viral clearance accelerated in moderate and severe cases, and clinical outcomes improved markedly by day six. Among moderate cases, 63.6 percent of treated patients resumed normal activities compared with 10.9 percent of controls, and half of severe cases were discharged from hospital versus just 2.8 percent on placebo. Researchers attribute this synergy to the combined flavonoids, phenolics, and fatty acids in the two substances, which may jointly impede the spike protein’s interaction with its receptor while adding antioxidant and antimicrobial effects. A separate trial pairing the seed with vitamin D3 found faster viral clearance, reduced pro-inflammatory cytokines, and possible protection against acute lung injury and respiratory failure.

Not every trial was a triumph. A double-blind randomized study of mild COVID-19 patients, which tested multiple dosages of whole and powdered seeds against placebo in charcoal capsules, found no significant differences in symptoms, immune cell profiles, or inflammatory markers. The authors of the meta-analysis suggest the ten-day treatment window may have been too short, noting that studies of natural products typically run four to twelve weeks. Another trial reported gastrointestinal side effects, including nausea and diarrhea, among patients taking black seed capsules, even as those patients showed symptom improvements. These mixed results underscore that dose, formulation, duration, and disease severity all likely shape the therapeutic response.

The research team is candid about the limitations. The number of included studies is small, sample sizes are modest, follow-up periods varied across trials, and the geographic concentration in the Middle East and Pakistan may limit generalizability to other populations. Still, the consistency of the mortality, severity, and CRP findings across low-risk-of-bias trials gives the results a credibility that many supplement studies lack. The authors conclude that adding Nigella sativa to COVID-19 care appears to yield therapeutic benefits, particularly in lowering mortality, reducing inflammation, and preventing severe disease, while calling for larger and more rigorously controlled studies to confirm the effect. For now, the ancient seed occupies a promising but unproven middle ground: neither a miracle cure nor folklore, but a candidate worthy of the clinical trials that will ultimately decide its place in medicine.

Subject of Research: Efficacy of Nigella sativa (black seed) as a treatment for COVID-19

Article Title: Efficacy of Nigella sativa in COVID-19 patients: a systematic review and meta-analysis

Article References: Elrosasy, A., Taha, A. M., Mohamed, R. G., Ali, F. Y., Nguyen, D., Taha, N. A., Cadri, S., Omar, I., Elbanna, M., & Abouelmagd, M. E. (2026). Efficacy of Nigella sativa in COVID-19 patients: a systematic review and meta-analysis. Journal of Emergency and Disaster Medicine, 2(1), Article 1. https://doi.org/10.1007/s44467-025-00004-7

Image Credits: AI Generated

DOI: 10.1007/s44467-025-00004-7

Keywords: Nigella sativa, COVID-19, meta-analysis, thymoquinone, SARS-CoV-2, phytomedicine, randomized controlled trials, C-reactive protein, mortality, cytokine storm, black seed, immunomodulation